This reading list we received from Drs entirely disinterested. E. Valstar, (Orthomolecular) doctor / biologist. We provide this list are unchanged for publication. .
Scroll down for list.
Valstar wrote the book Nutritional intervention in cancer, a signal to the conventional oncology. See description on page, etc. ISBN cancer rates. We want to mention that we have no business or substantive ties with Engelbert Valstar, but this book and lists seem to us so interesting that we want to change places. Questions / comments can be sent to the editor: redactie@kanker-actueel.nl We will keep your questions / comments to be forwarded Valstar. Also on this list and further information on this page is of course our disclaimer applies.
More detailed descriptions and other studies see and nutrition research. And we try to at least the abstract and the results of the Phase III trials and pivotal Phase II studies in the literature list and nutrition research. or current mainstream research to publish or not fitted comments.
For regular treatments in general because the only randomized study possible side effects. Moreover, a randomized study of conventional treatments often never implemented. This assertion of Valstar based on relevant literature is in NTvG (see NTvG 136: 709-710, 1992) by the respective oncologists not contradicted.
See also Nutritional Oncology, Heber D. et al ISBN 0-12-335960-0, the book was edited by Harvard and by the Memorial Sloan Kettering Institute! ).
(Editors note: See extensive bibliography in the book of Valstar Nutritional intervention in cancer, a signal to the conventional oncology and now as published on this site)..
To this list are Hans Houtsmuller, Ed Woerlee Johan Bolhuis and important contributions.
Bibliography of studies cancer and nutrition / supplementation. Studies: 701 t / m 800
701) Pommier P et al, J Clin Oncol 22: 1447-1453, 2004, Calendula officinalis is superior to trolamine to dermatitis associated with radiation for breast cancer prevention.
702) Zhao JX et al, Zhongguo Zhong Xi Yi Jie He Za Zhi 23: 908-10, 2003; Fuzheng Yiliu randomized study promotes apoptosis in esophageal cancer significantly.
703) Semiglasov VF et al, Anticancer Res 24: 1293-302, 2004, in addition to adjuvant mistletoe as an additional adjuvant CMF treatment for breast cancer improves quality of life.
704) BK Piao et al, Anticancer Res 24 :303-9, 2004, Mistletoe reduces chemotherapy side effects in various cancers (ovarian, NSCL and breast cancer) and improves the quality of life.
705) EC Purves et al, Br J Urol 51 :278-82, 1979, Corynebacterium parvum Subcutaneous injections besides standard treatment improves the survival of bladder cancer patients do not.
706) Papac R et aL, Cancer Res 38: 3150-3, 1978; BCG improves with advanced head and neck cancer the prognosis is not, it seems in other studies that BCG only in a not too large tumor load and chemotherapy in multiple meaningful is throat cancer.
707) Burnett AK et al, Blood 93: 4131-43, 1999, ATRA improves the cure rate of patients with promyelocytic leukemia in the ATRA as first-line treatment is applied, it shows that this only applies if the WBC is not too high .
708) Shen ZX et al, Proc Natl Acad Sci USA 101 :5328-35, 2004, Arsenic trioxide is as good as when it counts atra promyelocytic leukemia with a regression to achieve, with the combination that is faster and with respect to many clinical relevant parameters works together synergistically.
710) Separate C et al, Nutrition 20, 249-54, 2004, Glycyl-glutamine enhances neutrophil recovery levels after intensive chemotherapy because of leukemia in neutropenic fever but there was absolutely no effect.
711) DA De Luis et al, Eur J Clin Nutr 2004 May 12; arginine reduces fistula formation as a complication due to throat cancer.
712) Mayr AC et al, Dev Biol Stand 38: 553-7, 1977; Corynebacterium parvum in patients with metastatic breast cancer indicates that CMF will not significantly more regressions, moreover, there is a trend with Cp longer life, yet I commend Corynebacterium parvum in metastatic breast cancer yet.
713) Makowka L et al, Can J Surg 23: 429-31, 1980; BCG besides 5-FU improves the prognosis of patients with advanced gastric cancer is not.
714) Alberts DS et al, Gynecol Oncol 32: 16-21, 1989, Corynebacterium parvum improves with untreated ovarian cancer patients stage 3 the response to DCP (doxorubicin, cyclophosphamide and cisplatin).
715) Smith, RE et al, JNCI, 96: 1128-1132, 2004: BCG as adjuvants in cancer stage 2 / 3 improves the 10-year survival significantly.
716) O'Brien ME et al, Ann Oncol. 15: 906-14, 2004; Mycobacterium vaccae improves chemo in patients with advanced non-small cell lung cancer quality of life, survival is just not significantly better, with no 353 there is a better survival there.
717) Sato Y et al, J Immunother. 27: 394-7, OK-432 improved in this small study does not demonstrate the prognosis of patients operated on for stomach cancer that also get additional chemotherapy, other studies in this list show that OK-432 gastric cancer prognosis of patients (with a lower forecast ) improves, certainly when there is metastasis. For curative surgery, the meta-analysis of Sakamoto J et al, J Immunother 25: 405-12, 2002 unambiguously positive for OK-432.
718) Weijl NI et al, Eur J Cancer 40:1713-23, 2004: In randomized study did not protect C, E and selenium effects against cisplatin, however, with stratification.
719) Shen ZX et al, Proc Natl Acad Sci USA 101: 5328-35, 2004, Arsenic and ATRA in acute promyelocytic leukemia working synergistically: faster response and a significantly better persistence of a complete response by combination!
720) Toma S et al, Oncol Rep 11: 1297-305, 2004, 13-cisretinoinezuur radically improves prognosis of throat cancer is not treated, see 216.361 and 422: as adjuvant 13-cis-retinoic acid is indeed questionable as throat cancer is concerned, for prevention of new primary cancer of the throat it would seem to make sense.
721) Esselle JH et al, Ann Intern Med 128: 975-81, 1998; Ursodiol is veno-occlusive disease of the liver as a complication of bone marrow transplantation for, see also 307.
722) H Ekert et al, Medical and Pediatric Oncology :353-August 60, 1980, Children with successfulAAL were next treated for maintenance chemo or not BCG: remission duration and survival, which was already very good (make impact difficult to measure BCG) BCG were not better. See also 404 444 and 454: BCG is most interesting for a better response to chemotherapy in second line, evidence of improved survival with BCG by AAL is not. BCG in AML will certainly have a better survival, as in bladder and colon cancer (for example, but again not in malignant melanoma).
723) Fossa SD et al, Cancer 101 :533-40, 2004, 13-cisretinoinezuur increases the likelihood of response to interferon in metastatic renal cancer significantly.
724) Dalais FS et al, Urology 64, 510-5, 2004; Soy bread instead of wheat bread, the bags instead of PSA in prostate cancer patients are increasing the ratio of free / bound PSA changes with positive soy bread, according to this randomized study.
725) Heller AR et al, Int J Cancer 111:611-6, 2004; Fish weight loss is associated with abdominal surgery for cancer compared to other fat, liver and pancreas recover faster, also gave fish oil trend: many risk of sepsis but a shorter stay in intensive care. See abstract here
726) Hubay CA et al, J Steroid Biochem 23:1147-50, 1985; Additionally, because breast cancer adjuvant CMF alongside / BCG hormonal therapy improves disease-free survival at 6 years follow-up is not.
727) Toma S et al, Oncol Rep 10: 1895-901, 2003, Beta Carotene reduces throat cancer recurrence is not, nor fewer new primary cancer of the throat, no difference in cardiovascular disease, a non-significant reduction in total mortality in the beta -carotene group of 40%. It is clear that even with this small-scale study known ATBC study, which was bad already refuted.
728) Braga M et al, Arch Surg 134: 428-33, 1999, Omega-3 fatty acids, L-arginine and RNA reduction in patients undergoing abdominal surgery for cancer to the risk of infection, moreover, the shortened length of stay, and this fact In numerous other studies also found this list.
729) Su CK et al, Int J Oncol Biol Phys Radiate 60: 171-6, 2004; Aloe vera reduces randomized study radiation for throat cancer effects are not significant.
730) PR Schloerb and Amare M, pling 17: 407-13, 1993, Glutamine reduces randomized double-blind studies length of stay in hospital after bone marrow transplantation.
731) Oberbaum M et al, Cancer 92:684-90, 2001; Traumeel S stomatitis significantly reduces randomized study in children who receive bone marrow transplants. See abstract here
732) Creagan ET et al, J Clin Oncol 9: 2104-9, 1991, in addition to aspirin improves interferon in patients with advanced kidney cancer survival compared with interferon alone is not significant.
733) Moses AW et al, Br J Cancer 90: 996-1002, 2004, EPA is doing randomized study motility of pancreatic cancer patients with cachexia increase significantly, in line with improving the quality of life.
734) RR Xu et al, Zhongguo Zhong Xi Yi Jie He Za Zhi 24: 411-4, 2004, with yin supplementation and the so-called "clearing heat principle 'found in randomized studies in patients with acute myeloid leukemia with ATRA and arsenic a significantly better results may say more regressions, also immune functions, HB and platelets by these Chinese treatments were better than the only ATRA and arsenic-treated group.
735) Balzarini A et al, Br J homeopaths 89: 8-12, 2000, Belladonna promotes randomized, double-blind study recovery from side effects of radiation.
736) Van Patten CL et al, J Clin Oncol 20: 1449-1455, 2002; Soy phyto estrogens reduced in this study does not demonstrate the number of hot flushes due to menopause, see 500: In this study, not fewer, shorter hot flushes, and the transition occurs in breast cancer treatment is often a forced and therefore, this type of research in this list.
737) Belhabri A et al, Hematol J 3:49-55, 2002; ATRA offers nothing extra in addition to chemotherapy in relapsed acute promyelocytic myeloid leukemia
738) K. Ito et al, Int J Colorectal Dis 19:157-64, 2004; PSK decreases in patients operated on for Dukes' stage C colon cancer mortality due to cancer, disease-free survival improved in this study by not detectable.
739) Bylund A et al, Eur J Cancer Prev 12: 407-15, 2003, Rye bread wheat significantly increased compared with the apoptosis in prostate cancers.
740) Buzdar AU et al, Cancer 53: 384-9, 1984; BCG as an extraadjuvant treatment of breast cancer improves disease-free survival and survival s not, this result is consistent with other research: BCG is explicitly important in bladder cancer, AML, cancer and NHL, but explicitly not in breast, lung, Hodgkin's disease and malignant melanoma.
741) Salvati F et al, G Ital Chemioter 31: 185-9, 1984; Thymostimuline chemotherapy improves outcomes in small cell lung cancer limited disease when it is concerned, except in cases of extensification disease have limited frequency on disease significantly improves the Karnofsky index; regression and survival probability tended to be better with only very thymostimuline, see also the three other studies in this regard thymostimuline list in NSCLC, appears to have only sense thymostimuline IGI limited disease and reduced immunity.
742) Pearson OH et al, Breast Cancer Res Treat S61-8, 1983, in addition to BCG adjuvant CMF and tamoxifen as further improves the prognosis of breast cancer is not, which is often found!
743) Popiela T et al, Anticancer Res. 8: 1423-7, 1988, in addition to 5-FU shows BCG in patients with advanced gastric cancer is life extension, while 5-FU alone does not give respect to the control group.
744) Popiela T et al, Gastric Cancer 7: 240-5, 2004, in addition to BCG FAM provides an additional adjuvant surgery after a 10-year bank better society compared to chemotherapy as FAM, FAM compared to the control group did no better forecasting results, see except 743 and 744, including 511 of this list, in gastric cancer seems to be working again BCG, like NHL, AML, bladder, etc.
745) Creasman WT et al, Gynecol Oncol. 39:239-43, 1990; BCG as an adjuvant added to the CAP next forecast is not, incidentally was later shown that CAP is not better than P (cisplatin).
746) Schlenk RF et al, Leukemia 18 :1789-803, 2004, in patients with AML, never previously treated with chemotherapy with ATRA in randomized studies to improve disease-free survival and survival sec.
747) Clark RE et al, Br J Haematol 66: 77-83, 1987, in patients with myelodysplastic syndrome, 13-cisretinoinezuur enhances the antigen pattern, however, is only improved survival in patients without sideroblasts, and with less than 5% blasts.
748) Garland R et al, Int J Cancer 113: 835-40, 2005, in a randomized double-blind study in prostate cancer patients was a combination of phytoestrogens, antioxidants including carotenoids, selenium and other natural substances, a decrease of testosterone and DHT seen also was the doubling time of free PSA to decline, this fits with a slowing of the disease process.
749) ED Faure et al, Menopause 9: 329-34, 2002, 75 mg daidzein plus genistein reduce hot flushes because of the transition, which is relevant to the treatment of breast cancer: the transition iha or earlier if the symptoms are reinforced ( the latter mainly by aromatase inhibitors), see also 500 and 736, the latter study was almost certainly an insufficient dose.
, Br> 750) Nikander E et al, "Obstet Gynecol 101:1213-20, 2003; Isoflavones not significantly reduce menopausal symptoms in women with breast cancer, see also 500 736 and 749, a preliminary meta-analysis has yet to menopause isoflavones frequency on a beneficial effect .
751) Colombo R et al, J Urol 155: 1227-1232, 1996, Hyperthermia increases as in several other studies have found (see this list) the result of intravesical chemotherapy: more regressions by hyperthermia in neoadjuvantsituatie.
752) Garami M et al, J Pediatr Hematol Oncol 26: 631-5, 2004, Avemar, a fermented wheat germ extract decreases in children with cancer who receive chemotherapy the risk of neutropenia plus fever.
753) Farreras N et al, Clin Nutr 24 :55-65, 2005, arginine plus omega-3 fatty acids and RNA / DNA in a randomized trial accelerates wound healing after surgery for gastric cancer and reduces the number of complications, which is actually many times found.
754) Wilbur DW et al, J Surg Oncol. 34:165-9, 1987; In ovarian cancer stage 3 / 4 enhances cisplatin cyclophosphamide results in terms of survival is not, BCG is not proven, but the trend (P <0.08) still shows an effect of BCG in ovarian cancer . See also reference 745 and 2 below.
755) Alberts DS et al, Gynecol Oncol 32:8-15, 1989; In stage 3 / 4 of ovarian cancer improves outcome of BCG plus cyclophosphamide adriamycin no, not even of cisplatin, but the result of chemotherapy combined these three (longer response and longer survival).
756) Alberts DS et al, Gynecol Oncol. 32:16-21, 1989, in stage 3 / 4 of ovarian cancer improvesBCG plus cyclophosphamide result of adriamycin and cisplatin also not, but hey here are the three cytostatics not the three of us combined.
757) MB Popp et al, Cancer Treatment Rep. 65 Suppl 5: 129-35, 1981; Giving extra food (calories) improves in patients with diffuse lymphoma of the toleratie not chemo. Many previous studies in this list, the futility of TPN also shown.
758) Mertes N et al, Clin Nutr 19:395-401, L-alanyl-L-glutamine supplement shortened hospital stay after abdominal surgery significantly.
759) Morlion BJ et al, Ann Surg 227:302-8, 1998, this study is similar to no 758 and has a similar outcome.
760) Pytlik R et al, Bone Marrow Transplant 30:953-61, 2002, L-alanyl-glutamine reduced in cases of diarrhea aotologe transplant detectable, but more mucositis, a higher opiate use, a longer hospital stay and a higher risk of recurrence. For such patients, this dipeptide therefore not recommended.
761) MB Popp et al, Surgery 90:195-203, 1981; Intravenous extra nutrition improves survival of patients with advanced diffuse lymphoma not, it occurred to provide the necessary additional complications, this confirms again, additional power is useless sec.
762) HM Jian et al; pling 23 (5 Suppl): S62-6, 1999, L-alanyl-glutamine reduced in this study after abdominal surgery the hospital stay, the intestinal permeability was also better in the dipeptidegroep, in the placebo group, there was a trend toward more infections. See also 759 and 760.
763) Van Eys J et al, Med Pediatr Oncol 8:63-73, 1980; Intravenous hyper maintenance chemotherapy improves outcome is not detectable, infection does occur related to the maintenance of state, also see eg 761.
764) Morabito N et al, J Bone Miner Res 17, 1904-12, 2002, Genistein is in women who are just in the transition from osteoporosis, relevant to women with cancer through cancer treatment in the menopause stream.
765) C. Persson et al, Nutrition 21:170-8, 2005; Fish oil and melatonin are cachextische in gastric cancer patients as well to further cachexia / or the weight increases again, the combination works is still significantly better.
766) Nixon DW et al, Cancer Treat Rep. 65 Suppl 5:121-8, 1981; TPN (total parenteral nutrition) does not improve the chance of regression in patients with advanced colorectal cancer nor their survival.
767) Chen L et al, JNCI 93:1872-9, 2001; more lycopene in the form of tomato sauce (30 mg) reduced in patients who are nominated for prostatectomy (otherwise useless) the significant PSA, see also 21 and 421 .
768) Serrou B et al, Recent Results Cancer Res. 80: 246-53, 1982; extra fat, sugar and amino acids improve chemotherapy for oat cell lung cancer results in no small randomized study, which is consistent with the orthomolecular approach.
769) Shamberger RC et al, Am J Med 74:40-8, 1983; extra food in addition to chemotherapy for bone cancer is useless, the recovery of platelets and granulocytes was in the control group and even better in relation to it was in this group the lower transfusion requirements.
770) Shamberger RC et al, Surgery 96:1-13, 1984; In this randomized trial, with no extra calories found therapeutic benefit in patients receiving chemotherapy for bone cancer.
771) Lund Holm K et al, Cancer 100:1967-77, 2004; Patients with cachexia due to cancer were all COX-2 inhibitors and EPA, half also received nutritional support, focusing on inflammation, anemia prevention, and the nutritional status improve. Extra calories was not the primary goal, and now there was talk of life extension in the diet group.
772) JJ Barlow et al, Cancer 46:1333-8, 1980, folic acid plus methotrexate and cyclophosphamide in ovarian cancer is stage 3 / 4 superior to 5-FU plus cyclophosphamide, at least as far as the risk of regression is concerned, Crynebacterium parvum also showed the risk no influence on regression.
773) Clamon GH et al, Cancer Treat Rep 69:167-77, 1985; Hyper Alimony improved in patients with small cell lung carcinoma response to chemo / radiotherapy is not; state alimony was just more febrile episodes to go together.
774) Wolmark N et al, J Clin Oncol 17:3553-9, 1999, 5-FU plus leucovorin provides a demonstrably better disease-free survival in colorectal cancer patients stage B / C or 5-FU plus levamisole, something which in fact has already been demonstrated.
775) Tsavaris N et al, Oncol Rep 12:927-32, 2004; In patients with rectumca. shows adjuvant treatment with 5-FU plus leucovorin for six months as well as 5-FU plus levamisole 1years and that significantly reduced side effects, among others, see 774.
776) Parnes HL et al, J Clin Oncol 21:1819-24, 2003, in patients with metastatic breast cancer leucovorin adds nothing to the therapeutic effect of FAC.
777) Jordan WM et al, Cancer Treat Rep 65:197-205, 1981; Hyper Alimony does in patients with advanced lung cancer next to no benefit FACP cures, or iatrogenic complications occur.
778) Gianotti L et al, Pancreas 21:344-51, 2000, arginine plus RNA and omega-3 fatty acids together reduce the number of complications after pancreaticoduodenectomy and shorten the length of stay in hospital, many times facts found.
779) Di Costanzo F et al, Ann Oncol 14:1365-9, 2003, leucovorin levamisole in addition to adding anything extra to 5-FU as adjuvant for stage C colorectal cancer, but what one forgets is that leucovorin is superior to levamisole, so next 5-FU with leucovorin in colorectal cancer may be sufficient, see the numbers 321,774, 775 and 780.
780) Scheithauer W et al, Br J Cancer 77:1349-54, 1998, as an adjunct to surgery because of colon cancer patients stage 3, 5-FU plus leucovorin is superior to 5-FU plus levamisole.
781) Bellantone R et al; pling 12:195-7, 1988; extra calories and extra nitrogen nutrition in intestinal surgery due to cancer have no effect on the risk of septic complications, etc. In subgroup analysis, there was malnutrition in real (ie a too low albumin) slightly less risk of severe sepsis, but it remains a subgroup analysis.
782) Pan B et al, World J Gastroenterol 11:439-42, 2005; A Fuzheng Yiliu extract reduces the side effects of chemotherapy in cases of advanced gastric cancer so that the quality of life significantly improved very relevant immune parameters improved by the extract.
783) Drott C et al, Surgery 103:499-506, 1988; Intermittent extra calories for patients who receive chemotherapy for testicular cancer, the weight loss associated with chemotherapy and those who quite prolonged undetectable against.
, Br> 784) Hays DM et al, Med Pediatr Oncol 11:134-40, 1983; TPN reduced infection susceptibility in children with acute non-lymphocytic leukemia is not; extra calories have consistently shown no such fact, immuno-nutrition (arginine, RNA and Omega-3 fatty acids), by contrast, often make sense. All this is true, it should be recalled with the orthomolecular thought.
785) Chen Z et al; Zhong Xi Yi Jie He Xue Bao 1:184-6, 2003; Cinobufacini injections inhibit growth primary liver cancer, prolong life and improve quality show such randomized study.
786) Mayr AC et al, Dtsch Med Wochenschr. 104:1739-43, 1979; Corynebacterium parvum enhances performance fee when the metastatic breast cancer not chemo, 370,373 and 712 in conjunction with this conclusion is general.
787) Zhang B et al; Zhong Yao Cai 27:387-9, 2004; Jia Wei Si Zi Tang Jun. improves liver cancer randomized study regular treatment outcome significantly.
788) ZQ Meng et al; Zhong Xi Jie He Xue Bao 1:187-8,233, 2003, Traditional Chinese Medicine (TCM) to improve in randomized studies in patients with metastatic colorectal cancer significantly the result of arterial chemoembolisatie (TACE) that is less subsequent metastases distance later and a better median survival.
789) Cao Y et al; Shanghai Kou Qiang Yi Xue 5:1-3, 1996, TCM randomized study improves survival according to multivariate analysis of patients with squamous cell carcinoma of the throat.
790) Lin GC et al; Shanghai Kou Qiang Yi Xue 12:321-3, 2003, Shen Yang improves survival of patients with squamous cell carcinoma of the throat is not significant at first analysis.
791) Weiner RS et al, J Clin Oncol 3:949-57, 1985; Hyper Alimony does not give better results for the frequency on chemotherapy small cell lung cancer, or to more complications presentable!
792) M Valdivielso et al, Cancer 59:362-9, 1987; Hyper Alimony improved in this research is not the result of chemotherapy in patients with small cell lung cancer.
793) Uyl-de Groot CA et al, Vaccine 23:2379-87, 2005; A vaccination of colon cancer cells with improved BCG as an adjuvant in cancer patients with stage 2 / 3 survival significantly, which is consistent with the preliminary meta-analysis I regard this list BCG and cancer have already made.
794) the Reijk TM et al, J Urol 173:405-9, 2005; BCG as adjuvant in cases of bladder cancer indicates that surgically treated compared with epirubicin longer disease-free survival there than epirubicin, for the survival seconds is a long follow-up is needed, does BCG for bladder cancer based on the meta-analysis is always better than chemo.
796) Vasanthan A et al, Int J Oncol Biol Phys 61:145-53 Radiate, 2005, Hyperthermia enhances overall result of irradiation locally advanced cervical cancer.
797) Zuo Y et al, Zhonghua Zhong Liu Za Zhi 26:247-9, 2004, Hyperthermia in addition to chemotherapy prolongs life in case of advanced gastric cancer compared to chemotherapy alone, even by hyperthermia occur in fewer gastrointestinal problems.
798) K. Kitamura et al, J Surg Oncol 60:55-8, 1995; Hyperthermia improves outcome of locally advanced esophageal cancer in patients with chemoirradiatie and improves their long term survival.
799) Sugimachi K et al, Int J Hyperthermia 10:485-93, 1994, Hyperthermia in patients with esophageal cancer show clear regression by promoting chemo.
800) Headley JA et al, Oncol Nurs Forum 31:977-83, 2004; Additional exercise turns sitting in randomized studies in women with advanced breast cancer who receive chemotherapy at the physical well being longer detectable level. Fewer calories (see study below No. 11) alone or in combination with extra exercise are beneficial in breast cancer. Extra calories are just cancer in general rather poor. All this correlates with epidemiological studies that overweight (overeating and / or sedentary lifestyle) in the period a preventive risk factor for cancer.
